634 RESULTS FROM THE BARRETT'S OESOPHAGUS TRIAL 3 (BEST3): A RANDOMISED CONTROLLED TRIAL COMPARING THE CYTOSPONGE™-TFF3 TEST WITH USUAL CARE TO IDENTIFY OESOPHAGEAL PRECANCER IN PRIMARY CARE PATIENTS WITH CHRONIC GASTROESOPHAGEAL REFLUX
Volume
158
Pagination
s - 136
DOI
10.1016/s0016-5085(20)31020-9
Journal
Gastroenterology
Issue
ISSN
0016-5085
Metadata
Show full item recordAbstract
AGA Abstract